-
Virion Therapeutics Reports Broad and Sustained Anti-HBV Immunity Following a Single VRON-0200 Dose in the Majority of Chronically HBV-Infected Patients From its Phase 1b Study at CROI 2026
Virion Therapeutics, LLC, a clinical-stage biotechnology company developing novel T cell-based immunotherapies that
Lifestyle Content
Technology
-
Little Scholars Daycare Chelsea Offers Guidance on Choosing the Right Infant Care Program for Working Parents
-
Baby Chiropractor Costa Mesa Shares Expert Tips for Easing Common Infant Discomforts Naturally
-
Andatel Grande Patong Phuket: 40-50M THB Mold Remediation After 6-Year Coastal Closure
-
Local Day Care in Downtown Brooklyn Shares Warning Signs That Signal Readiness for Preschool Transition
-
Zeagoo Selection，2026 Spring/Summer Wardrobe Revolution: Effortlessly Elegant Outfits for Mature Women
Entertainment
-
UK Financial Ltd Sets February 27 CATEX Debut for VENUS Coin, Opening Limited Early Access Through MayaPro Wallet
-
Ice Melts. Clean Water Fails. A Startup Thinks It Has the Fix
-
Capsadyn® Launches on Amazon, Offering Non-Burning Capsaicin Pain Relief
-
Delay In Federal Disaster Assistance Causing Failure Of Small Business In Disaster Areas
-
Off The Hook YS (NY SE: OTH) Executes Transformational Apex Acquisition, Creating Vertically Integrated Marine Powerhouse with $60M Inventory Capacity
Health
-
Consumer spending trends: Why exclusive retail and discount shopping keep winning
-
The most common challenges in managing a med spa
-
How to manage registration and payments for large events
-
Early 2026 housing trends: Rates improve, incentives expand, confidence lags
-
Fundraising readiness is a cap table problem, not a pitch deck problem
